01—Abstract
Summary
Summary of the 8-K filed February 26, 2024. Cited figures are marked; the original filing is the authoritative source.
ONEOK's (OKE) February 26, 2024 8-K furnishes its fourth-quarter and full-year 2023 earnings release and 2024 financial guidance.
Full-year 2023 net income was about $2.7 billiona ($5.48 per diluted share) and adjusted EBITDA exceeded $5.2 billion, but these figures are inflated by one-time items. The largest was a $779 million insurance settlement gain tied to the Medford incident, partly offset by $146 million of third-party fractionation costs, with $158 million of transaction costs also included. Results also reflect a partial year (from September 25, 2023) of the Magellan refined products and crude business, which contributed $465 million of adjusted EBITDA.
Underlying growth was strong: Rocky Mountain and Gulf Coast/Permian NGL throughput rose sharply, natural gas processed rose 14%, and wells connected rose 54%. Management guided to 2024 net income of $2.61b–$3.01 billion (midpoint $2.8 billion), adjusted EBITDA of $5.9–$6.3 billion (midpoint $6.1 billion, implying double-digit growth on a reported basis as the 2023 comparison is distorted by one-time items), and total capital expenditures of $1.75–$1.95 billion. Management cited roughly $175 million of midpoint realized synergies from the Magellan deal in its first year, with about $125 million more expected in 2025.
Capital returns are a clear priority: the dividend was raised 3.7% to $0.99c per quarter, a $2 billion share repurchase program was authorized, and $1.3 billion of debt was retired in 2023. Leverage was 3.46x net debt-to-EBITDA at year-end 2023, above the stated 3.5x target only marginally and below it, with $2.5 billion of undrawn credit capacity and $338 million of cash. Investors should weigh the strong volume momentum and synergy path against the elevated post-Magellan debt load ($21.7 billion total debt at year-end), the non-recurring nature of the 2023 Medford gain, and the risk that synergy and growth targets may not be fully realized, as the release's forward-looking statements caution.
02—Key points
Key Highlights
- FY2023 net income of $2.66 billion ($5.48 diluted EPS) and adjusted EBITDA of $5.24 billion, both boosted by a one-time $779 million Medford insurance settlement gain
- Q4 2023 net income of $688 million ($1.18 diluted EPS) and adjusted EBITDA of $1.51 billion, with Rocky Mountain NGL throughput up 20% year over year
- 2024 guidance: net income of $2.61–$3.01 billion, adjusted EBITDA of $5.9–$6.3 billion, and total capex of $1.75–$1.95 billion
- Magellan acquisition closed September 25, 2023; the refined products and crude segment contributed $465 million of adjusted EBITDA in its partial first period, and management expects $160–$190 million of 2024 realized synergies
- Shareholder returns: quarterly dividend raised 3.7% to $0.99 per share ($3.96 annualized) and a new $2 billion share repurchase authorization targeted over roughly four years
- Balance sheet: 3.46x annualized Q4 net debt-to-EBITDA, $1.3 billion of 2023 debt extinguished, $2.5 billion credit facility undrawn, and $338 million cash
- Growth projects: Elk Creek pipeline expansion to 435,000 bpd (575,000 bpd total Rocky Mountain NGL capacity) for about $355 million, due Q1 2025; Saguaro Connector final investment decision expected by mid-2024 after FERC approval of its Presidential Permit
03—Questions
Frequently Asked Questions
How much of the 2023 earnings were driven by one-time items?
A large share. The Medford incident produced a $633 million pre-tax net benefit for the year, comprising a $779 million insurance settlement gain offset by $146 million of third-party fractionation costs. Transaction costs of $158 million for the Magellan deal were a partial offset, and the release states the Medford benefit contributed about $0.87 per diluted share after tax on a net basis, with the full-year impact of these items netting to a $0.87 EPS benefit. Investors should look to 2024 guidance, which explicitly excludes the 2023 Medford settlement, for a cleaner comparison.
Why does 2024 guidance imply growth if 2023 was so strong?
Because 2023 was inflated by the Medford gain. Guided 2024 adjusted EBITDA of $5.9–$6.3 billion compares with reported 2023 adjusted EBITDA of $5.24 billion, which includes the $779 million settlement gain. Excluding the one-time items, management guides to double-digit adjusted EBITDA growth, driven by a full year of the Magellan refined products and crude business, higher NGL volumes, roughly 7% more natural gas processed, and synergies of about $175 million at the midpoint.
How is the Magellan acquisition performing and what synergies are expected?
The refined products and crude segment contributed $465 million of adjusted EBITDA from the September 25, 2023 closing through year-end, including a $40 million unfavorable inventory adjustment related to closing. Refined products shipped averaged 1.55 million bpd and crude shipped 808,000 bpd in that period. Management expects $160–$190 million of realized annual cost and commercial synergies in 2024, with about $125 million of additional synergies in 2025 and further commercial synergies in 2026 as capital projects finish.
Is the dividend and buyback program sustainable given leverage and capex?
Management targets a 3%–4% annual dividend growth rate and expects combined dividends and buybacks to trend toward 75%–85% of forecast cash flow from operations after capex over the next four years, with a target debt-to-EBITDA of about 3.5x. Year-end 2023 leverage was 3.46x, and operating cash flow in 2023 was $4.4 billion against $1.8 billion of dividends paid. Total debt rose to roughly $21.7 billion after the Magellan financing, so sustainability depends on delivering the 2024 EBITDA guidance and the synergy plan.
What are the main risks flagged in the release?
The forward-looking statements cite commodity price volatility, reliance on producer activity and third-party pipelines and refineries, operational hazards, and interest rate and credit market risk. They also flag risks specific to this period: the Magellan integration and whether anticipated synergies are realized, potential impairments, and leverage from the debt-funded acquisition, which could affect credit ratings and access to capital. Adjusted EBITDA is a non-GAAP measure, and the company notes it excludes some items that affect net income.
04—Continue